Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.02 | 1.81 |
NAV | ₹25.36 | ₹99.93 |
Fund Started | 26 Oct 2020 | 31 Jul 2008 |
Fund Size | ₹1790.90 Cr | ₹4721.61 Cr |
Exit Load | Exit load of 1% if redeemed within 3 months. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 32.70% | 40.29% |
3 Year | 18.06% | 23.65% |
5 Year | - | 23.58% |
1 Year
3 Year
5 Year
Equity | 96.76% | 97.40% |
Cash | 3.24% | 2.60% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.21% |
Reliance Industries Ltd. | 6.73% |
ICICI Bank Ltd. | 6.04% |
State Bank of India | 5.72% |
ITC Ltd. | 5.19% |
Grasim Industries Ltd. | 5.02% |
Infosys Ltd. | 4.82% |
Hindustan Unilever Ltd. | 4.24% |
Kotak Mahindra Bank Ltd. | 4.11% |
Indus Towers Ltd. | 3.34% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 6.21% |
ICICI Bank Ltd. | 5.26% |
State Bank of India | 4.04% |
Infosys Ltd. | 3.90% |
Larsen & Toubro Ltd. | 2.88% |
Bharti Airtel Ltd. | 2.83% |
Dr. Reddy's Laboratories Ltd. | 2.73% |
ITC Ltd. | 2.54% |
CESC Ltd. | 2.29% |
Biocon Ltd. | 2.21% |
Name | Fatema Pacha | Satish Ramanathan |
Start Date | 21 Dec 2020 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of maximum 30 companies across market capitalisation. | The scheme which aims to provide capital appreciation by investing primarily in equity and equity related securities of various market depending upon valuation discount or premium amongst Large / Mid & Small cap stocks, the fund will keep varying the weights to capture the value while keeping an optimum Risk / Return profile. |
Launch Date | 26 Oct 2020 | 31 Jul 2008 |
Description
Launch Date